What ARx does

ARx is a privately held pharmaceutical drug manufacturing company headquartered in Glen Rock, United States, founded in 2005. The company manufactures and supplies specialty drug-delivery formats — mucosal films, transdermal patches, adhesive coatings, and pharmaceutical ingredients — positioning it as a B2B supplier to pharmaceutical developers and marketers that need finished or semi-finished dosage forms and excipients. Its product portfolio spans multiple delivery technologies, suggesting a multi-platform manufacturing operation rather than a single-format contract manufacturer.

The company operates with a workforce of 51-100 employees and markets itself through its corporate website at arxpharma.com, although at the time of source capture the site displays only a verification/loading page and yields no additional first-party detail. No public disclosures are available on revenue, funding history, ownership, management team, certifications, customer base, geographic footprint, pricing, or product roadmap, which materially limits visibility into commercial mechanics and strategic direction.

Based on the firmographic profile (specialty pharma manufacturer, ~20 years operating history, sub-100 headcount), ARx most plausibly operates as a mid-sized CDMO/excipient/finished-dose supplier serving other pharmaceutical companies, but this characterization is inferred from the product mix and industry context rather than from a disclosed business model in the source data.

Name

ARx

Website

https://arxpharma.com

Company type

Private

Founded year

2005

Headcount range

51–100 employees

Short description

ARx is a privately held U.S.-based pharmaceutical drug manufacturer (founded 2005, 51-100 employees, Glen Rock) that supplies mucosal films, transdermal patches, adhesive coatings, and pharmaceutical ingredients to pharmaceutical customers.

Ownership category

akta.pro rank

Headquarters

HQ city

Glen Rock

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Core offering

ARx is a pharmaceutical manufacturer that produces and supplies mucosal films, transdermal patches, adhesive coatings, and pharmaceutical ingredients. The company operates as a specialty drug delivery manufacturer serving pharmaceutical industry buyers with physical dosage form and formulation component products. Founded in 2005 and based in Glen Rock, United States, ARx employs 51-100 staff in this manufacturing-focused business.

Differentiator

Problem solved

Functional benefit

Products and services

• Mucosal Films

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• Noven Pharmaceuticals: Subsidiary of Hisamitsu Pharmaceutical, Noven is a leading manufacturer of transdermal patches (e.g., Vivelle-Dot). Comparable to ARx in transdermal patch technology and serves as a benchmark for what scaled niche delivery specialists can become.
• Catalent: Large global CDMO with significant transdermal, oral, and specialty drug-delivery manufacturing capacity. Overlaps with ARx in patch and specialty dose-form manufacturing, though at much greater scale and breadth.

Emerging players

• IntelGenx Technologies: Canadian specialty pharma developing oral thin films and transdermal delivery platforms. Comparable to ARx's mucosal film expertise with an overlapping focus on novel non-oral drug delivery formats.

Direct peers

• Tapemark: Minnesota-based contract manufacturer specializing in transdermal patches and topical drug delivery. Closely mirrors ARx's focus on patch-based drug delivery for pharmaceutical customers.
• Kindeva Drug Delivery: Formerly 3M Drug Delivery Systems, Kindeva is one of the largest global CDMOs for transdermal patches and inhalation products. Directly comparable to ARx as a contract manufacturer of drug-delivery dosage forms for pharma partners.
• Aquestive Therapeutics: Specialty pharma company focused on oral and mucosal film drug delivery, including sublingual and buccal films. Directly comparable to ARx's mucosal film capabilities and partnership-driven commercial model.
• MedPharm: CDMO specializing in topical and transdermal formulation development and manufacturing. Comparable to ARx as a specialty drug-delivery CDMO serving pharma partners across development stages.
• Adare Pharmaceuticals: CDMO with capabilities in oral dose forms, multiparticulates, and taste-masked/mucosal delivery technologies. Comparable to ARx as a specialty drug-delivery manufacturer offering differentiated dosage-form platforms.
• Lohmann Therapie-Systeme: German manufacturer of transdermal therapeutic systems and adhesive-based drug delivery products. Highly comparable to ARx's transdermal patch and adhesive coating offerings.
• AdhexPharma: European leader in transdermal drug delivery patches and topical systems. Comparable to ARx in providing patch manufacturing services and proprietary adhesive coating technologies to pharma partners.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/arxpharma
• Facebookfacebook.com/arxllc
• LinkedInlinkedin.com/company/arx_llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARx